Fibroblast Growth Factor 23 in COVID-19: An Observational Study

Introduction: Fibroblast growth factor 23 (FGF23) belongs structurally to the endocrine FGF protein family, which also includes FGF19 and FGF21. In the past decade, FGF23 has emerged as a possible diagnostic, prognostic biomarker, and therapeutic target in several conditions. Data about COVID-19 and...

Descripción completa

Detalles Bibliográficos
Autores principales: Myrou, Athena, Aslanidis, Theodoros, Makedou, Keli, Mitsianis, Athanasios, Thisiadou, Aikaterini, Karalazou, Paraskevi, Chatzopoulos, Georgios, Papadopoulos, Anastasios, Kalis, Antonios, Giagkoulis, Dimitrios, Lezgidis, Fotios, Savopoulos, Christos
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cureus 2023
Materias:
Internal Medicine
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10460241/
https://www.ncbi.nlm.nih.gov/pubmed/37637614
http://dx.doi.org/10.7759/cureus.42561

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10460241/
https://www.ncbi.nlm.nih.gov/pubmed/37637614
http://dx.doi.org/10.7759/cureus.42561

Ejemplares similares